Creso Pharma Limited Financials
COPHFDelisted Stock | USD 0.12 0.00 0.00% |
Creso |
Understanding current and past Creso Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Creso Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Creso Pharma's assets may result in an increase in income on the income statement.
Creso Pharma Stock Summary
Creso Pharma competes with Bionoid Pharma. Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
Business Address | 145 Stirling Highway, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.cresopharma.com |
Phone | 61 8 9389 3180 |
Currency | USD - US Dollar |
Creso Pharma Key Financial Ratios
There are many critical financial ratios that Creso Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Creso Pharma Limited reports annually and quarterly.Creso Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Creso Pharma's current stock value. Our valuation model uses many indicators to compare Creso Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Creso Pharma competition to find correlations between indicators driving Creso Pharma's intrinsic value. More Info.Creso Pharma Limited is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Creso Pharma's earnings, one of the primary drivers of an investment's value.Creso Pharma Market Pulse
Quote | 0.12 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.12 |
Low | 0.12 |
High | 0.12 |
Volume | 0 |
Exchange | PINK |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |